ORPH Phase III narcolepsy data

Orphan Medical (ORPH) said in the double-blind Phase IIIb EXCEEDS trial in about 200 patients with excessive daytime sleepiness (EDS) associated with narcolepsy, Xyrem sodium oxybate monotherapy met t...